Latest news
Jun 10, 2022 01:57 PM
Refining the teaching tools by creating better scientific an...
Research into visual scientific communication offers new insights into how to design the best visual aids to help teachers teach science.
MEDIA RELEASE: Jun 09, 2022 10:47 AM
Stem-cell models reveal glaucoma secrets
Australian researchers uncover hidden genetic markers of glaucoma
May 17, 2022 12:30 PM
New funding boosts Garvan breast cancer research
NBCF backs Garvan researchers with $2.99 million in grants to improve treatments and uncover new therapies.
May 16, 2022 09:20 AM
Follow-up genetic testing gives patients further chance of d...
A new study shows that people can increase their chances of a diagnosis by 10 per cent if they have a follow-up analysis of their genetic test
May 11, 2022 05:55 PM
Garvan projects funded for next stages
More than $1.8 million has been awarded to Garvan researchers to fund projects for breast cancer and immune system modelling.
May 09, 2022 11:02 AM
Professor Chris Goodnow, Garvan’s Executive Director, recogn...
The American Association of Immunologists has awarded Professor Goodnow with the AAI-BioLegend Herzenberg Award
Apr 21, 2022 03:59 PM
Rare genetic mutation linked to risk of severe viral infecti...
Identifying a rare genetic mutation that weakens the immune system can better inform those who may be at higher risk of severe viral illness.
Apr 19, 2022 10:30 AM
New pathways to unlock genetic results for action
With increasing attention being paid to genetic findings in research, what does it mean for Australian researchers and research participants?
MEDIA RELEASE: Apr 08, 2022 08:28 AM
An immune ‘fingerprint’ reveals path for better treatment of...
Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune di...
Mar 18, 2022 12:32 PM
Professor Elgene Lim recognised for outstanding outcomes in ...
Cancer Council NSW awards Sally Crossing AM Award
MEDIA RELEASE: Mar 17, 2022 02:49 PM
$185 million investment to fast-track treatments for rare an...
The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub: building links from research through to the clinic; creating jobs; changing lives.
Mar 09, 2022 09:21 AM
Cancer Council NSW grants for Garvan researchers
Two teams at the Garvan Institute have been awarded project grants from Cancer Council NSW to explore innovative new frontiers in cancer research.
MEDIA RELEASE: Mar 05, 2022 06:00 AM
Single test for over 50 genetic diseases will cut diagnosis ...
Garvan researchers have shown how new genomic sequencing technology can reduce the 'diagnostic odyssey' experienced by people with rare neurological and neuromuscular diseases.
Mar 03, 2022 12:05 PM
US Defense Department backs breast cancer research
A Garvan project to explore a potential new approach to treating fibrosis in breast cancer has been awarded a grant from the US Department of Defense.
Feb 17, 2022 02:58 PM
Funding boost to Garvan’s pancreatic cancer research
PanKind foundation supports new study to improve immunotherapy outcomes in pancreatic cancer.
Jan 31, 2022 04:52 PM
Garvan community recognised in Australia Day Honours List
For significant contributions to science, leadership, philanthropy and the arts.
Jan 28, 2022 11:00 AM
Research reveals approach to improve therapy for childhood c...
Researchers at Garvan have identified a potential therapy that may improve how effectively chemotherapy targets neuroblastomas.
Jan 25, 2022 10:27 AM
Will an Omicron-specific vaccine help control COVID? There’s...
Dr Deborah Burnett outlines the pros and cons of variant-specific vaccines and the search for a universal COVID vaccine.
MEDIA RELEASE: Jan 06, 2022 01:37 PM
Common osteoporosis medication boosts immune response in lun...
Researchers have uncovered a mechanism by which bisphosphonates – a treatment commonly prescribed for osteoporosis – may help fight respiratory infections.
Jan 04, 2022 01:09 PM
A/Prof Thomas Cox awarded NHMRC Development Grant
Garvan’s Associate Professor Thomas Cox has received funding to investigate a new treatment approach for pancreatic cancer.
Dec 03, 2021 08:28 AM
Cancer Institute NSW funds early career research
CINSW awards Early Career Fellowships to two Garvan cancer researchers.